Stock Groups

EU antitrust decision on Thermo Fisher’s PPD deal due by Dec. 7 -Breaking

by Mike Robinson

[ad_1]

© Reuters. FILEPHOTO: This illustration photo, taken March 10, 2020 shows test tubes labeled “COVID-19. Test positive”. REUTERS/Dado Ruvic/Illustration/File Photo/File Photo

BRUSSELS, (Reuters) – The European Commission filed Wednesday that showed the $21 billion offer by Thermo Fisher Scientific (NYSE) for contract research company PPD (NASDAQ) Inc. The decision will be made by EU antitrust regulators on Dec. 7.

Thermo Fisher announced the agreement in April. It is the world’s biggest maker of instruments for science. With growing interest in virtual clinical trials, the contract research sector is recovering from pandemic disruption.

After its preliminary review, the European Commission can approve or deny the deal. If serious concerns are raised, the Commission can launch a 4-month-long investigation.

Disclaimer Fusion MediaThis website does not provide accurate and current data. CFDs are stocks, futures, indexes or Forex. The prices of Forex and CFDs are not supplied by exchanges. They are instead provided by market makers. Because prices might not reflect the market, they may be incorrect. This means that prices cannot be considered indicative and are inappropriate for trading. Fusion Media is not responsible for trading losses that may be incurred as a consequence of the use of this data.

Fusion MediaFusion Media and anyone associated with it will not assume any responsibility for losses or damages arising from the use of this website’s data including quotes and charts. Trading the financial markets is one of most risky investment options. Please make sure you are fully aware about the costs and risks involved.



[ad_2]